Compile Data Set for Download or QSAR

Found 230 hits with Last Name = 'laurent' and Initial = 'd'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592995 (US11578054, Example 1017) Show SMILES CC(=O)NC1CCN(CCCOc2cccc(c2Cl)-c2cccc3C(CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)CC1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.200	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474547 (US10882844, Example 1012) Show SMILES CCN(CC)C1CCC(CC1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r,wD:47.52,(-13.22,-.12,;-13.99,-1.45,;-13.22,-2.78,;-13.99,-4.12,;-13.22,-5.45,;-11.68,-2.78,;-10.91,-1.45,;-9.37,-1.45,;-8.6,-2.78,;-9.37,-4.12,;-10.91,-4.12,;-7.06,-2.78,;-6.15,-4.03,;-4.69,-3.55,;-3.35,-4.32,;-2.02,-3.55,;-2.02,-2.01,;-3.35,-1.24,;-4.69,-2.01,;-6.15,-1.54,;-.68,-4.32,;-.68,-5.86,;.65,-6.63,;1.98,-5.86,;1.98,-4.32,;3.32,-3.55,;4.65,-4.32,;5.98,-3.55,;5.98,-2.01,;7.32,-1.24,;7.32,.3,;5.98,1.07,;5.98,2.61,;4.65,3.38,;4.65,4.92,;5.98,5.69,;7.39,5,;7.32,3.38,;8.72,5.79,;10.04,6.58,;8.65,-2.01,;9.98,-1.24,;11.32,-2.01,;11.32,-3.55,;12.65,-4.32,;13.99,-3.55,;13.99,-2.01,;12.65,-1.24,;12.65,.3,;11.32,1.07,;13.99,1.07,;8.65,-3.55,;7.32,-4.32,;7.32,-5.86,;.65,-3.55,;.65,-2.01,)| Show InChI InChI=1S/C45H50ClN5O5/c1-4-50(5-2)36-15-12-32(13-16-36)44-49-39-21-33(14-17-41(39)56-44)37-10-8-9-34(29(37)3)28-55-43-22-42(54-27-31-19-30(23-47)24-48-25-31)35(20-38(43)46)26-51-18-7-6-11-40(51)45(52)53/h8-10,14,17,19-22,24-25,32,36,40H,4-7,11-13,15-16,18,26-28H2,1-3H3,(H,52,53)/t32?,36?,40-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474556 (US10882844, Example 1016) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CCN(CC(O)=O)CC1 |r| Show InChI InChI=1S/C42H42ClN5O7/c1-26-31(5-4-6-33(26)30-8-9-37-35(17-30)46-41(55-37)29-10-13-47(14-11-29)23-40(49)50)25-54-39-18-38(53-24-28-15-27(19-44)20-45-21-28)32(16-34(39)43)22-48-12-3-2-7-36(48)42(51)52/h4-6,8-9,15-18,20-21,29,36H,2-3,7,10-14,22-25H2,1H3,(H,49,50)(H,51,52)/t36-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474557 (US10882844, Example 1017) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CCOCC1 |r| Show InChI InChI=1S/C40H39ClN4O6/c1-25-30(5-4-6-32(25)29-8-9-36-34(17-29)44-39(51-36)28-10-13-48-14-11-28)24-50-38-18-37(49-23-27-15-26(19-42)20-43-21-27)31(16-33(38)41)22-45-12-3-2-7-35(45)40(46)47/h4-6,8-9,15-18,20-21,28,35H,2-3,7,10-14,22-24H2,1H3,(H,46,47)/t35-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474561 (US10882844, Example 1020) Show SMILES CN1CCC(CC1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)c1C |r| Show InChI InChI=1S/C39H40ClN5O6/c1-24-29(5-4-6-31(24)28-7-8-34-33(15-28)44-37(51-34)27-9-11-45(3)12-10-27)22-50-36-16-35(49-21-26-13-25(17-41)18-42-19-26)30(14-32(36)40)20-43-39(2,23-46)38(47)48/h4-8,13-16,18-19,27,43,46H,9-12,20-23H2,1-3H3,(H,47,48)/t39-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477028 (US10882844, Example 2006) Show SMILES C[C@@H]1C[C@H](N)CN1c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)c1C |r| Show InChI InChI=1S/C38H41ClN6O5/c1-23-9-30(41)18-45(23)37-44-33-12-27(7-8-34(33)50-37)31-6-4-5-28(24(31)2)20-49-36-13-35(48-19-26-10-25(14-40)15-42-16-26)29(11-32(36)39)17-43-38(3,21-46)22-47/h4-8,10-13,15-16,23,30,43,46-47H,9,17-22,41H2,1-3H3/t23-,30+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477014 (US10882844, Example 1030) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2ncc(nc2c1)C1=CCNCC1 |r,t:52| Show InChI InChI=1S/C41H39ClN6O4/c1-26-31(5-4-6-33(26)30-8-9-35-36(17-30)47-37(22-46-35)29-10-12-44-13-11-29)25-52-40-18-39(51-24-28-15-27(19-43)20-45-21-28)32(16-34(40)42)23-48-14-3-2-7-38(48)41(49)50/h4-6,8-10,15-18,20-22,38,44H,2-3,7,11-14,23-25H2,1H3,(H,49,50)/t38-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477026 (US10882844, Example 2003) Show SMILES C[C@@H]1C[C@H](N)CN1c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CNC(CO)CO)cc2Cl)c1C |r| Show InChI InChI=1S/C37H39ClN6O5/c1-22-8-29(40)17-44(22)37-43-33-11-26(6-7-34(33)49-37)31-5-3-4-27(23(31)2)21-48-36-12-35(47-20-25-9-24(13-39)14-41-15-25)28(10-32(36)38)16-42-30(18-45)19-46/h3-7,9-12,14-15,22,29-30,42,45-46H,8,16-21,40H2,1-2H3/t22-,29+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477027 (US10882844, Example 2004) Show SMILES CN[C@H]1C[C@@H](C)N(C1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN(C)C(C)(CO)CO)cc2Cl)c1C |r| Show InChI InChI=1S/C40H45ClN6O5/c1-25-11-32(43-4)20-47(25)39-45-35-14-29(9-10-36(35)52-39)33-8-6-7-30(26(33)2)22-51-38-15-37(50-21-28-12-27(16-42)17-44-18-28)31(13-34(38)41)19-46(5)40(3,23-48)24-49/h6-10,12-15,17-18,25,32,43,48-49H,11,19-24H2,1-5H3/t25-,32+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477031 (US10882844, Example 2009) Show SMILES CN1CCN(CC1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)c1C Show InChI InChI=1S/C38H41ClN6O5/c1-25-29(5-4-6-31(25)28-7-8-34-33(15-28)43-37(50-34)45-11-9-44(3)10-12-45)22-49-36-16-35(48-21-27-13-26(17-40)18-41-19-27)30(14-32(36)39)20-42-38(2,23-46)24-47/h4-8,13-16,18-19,42,46-47H,9-12,20-24H2,1-3H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477037 (US10882844, Example 2015) Show SMILES CN(Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3oc(nc3c2)N2CCN(C)CC2)cc1OCc1cncc(c1)C#N)C(C)(CO)CO Show InChI InChI=1S/C39H43ClN6O5/c1-26-30(6-5-7-32(26)29-8-9-35-34(16-29)43-38(51-35)46-12-10-44(3)11-13-46)23-50-37-17-36(49-22-28-14-27(18-41)19-42-20-28)31(15-33(37)40)21-45(4)39(2,24-47)25-48/h5-9,14-17,19-20,47-48H,10-13,21-25H2,1-4H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477039 (US10882844, Example 2017) Show SMILES CN(Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3oc(nc3c2)N2CCN(C)CC2)cc1OCc1cncc(c1)C#N)[C@@](C)(CO)C(O)=O |r| Show InChI InChI=1S/C39H41ClN6O6/c1-25-29(6-5-7-31(25)28-8-9-34-33(16-28)43-38(52-34)46-12-10-44(3)11-13-46)23-51-36-17-35(50-22-27-14-26(18-41)19-42-20-27)30(15-32(36)40)21-45(4)39(2,24-47)37(48)49/h5-9,14-17,19-20,47H,10-13,21-24H2,1-4H3,(H,48,49)/t39-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474518 (US10882844, Example 1001) Show SMILES CN1CCC(CC1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r| Show InChI InChI=1S/C41H42ClN5O5/c1-26-31(6-5-7-33(26)30-9-10-37-35(18-30)45-40(52-37)29-11-14-46(2)15-12-29)25-51-39-19-38(50-24-28-16-27(20-43)21-44-22-28)32(17-34(39)42)23-47-13-4-3-8-36(47)41(48)49/h5-7,9-10,16-19,21-22,29,36H,3-4,8,11-15,23-25H2,1-2H3,(H,48,49)/t36-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474566 ((S)-1-(2-(4-carboxycyclohexyl)benzo[d]oxazol-5-yl)...) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CCC(CC1)C(O)=O |r,wD:25.27,(.65,-2.06,;.65,-3.6,;1.98,-4.37,;3.32,-3.6,;4.65,-4.37,;5.98,-3.6,;5.98,-2.06,;7.32,-1.29,;7.32,.25,;5.98,1.02,;5.98,2.56,;4.65,3.33,;4.65,4.87,;5.98,5.64,;7.37,4.89,;7.32,3.33,;8.7,5.66,;10.03,6.43,;8.65,-2.06,;9.98,-1.29,;11.32,-2.06,;11.32,-3.6,;12.65,-4.37,;13.99,-3.6,;13.99,-2.06,;12.65,-1.29,;12.65,.25,;11.32,1.02,;13.99,1.02,;8.65,-3.6,;7.32,-4.37,;7.32,-5.91,;1.98,-5.91,;.65,-6.68,;-.68,-5.91,;-.68,-4.37,;-2.02,-3.6,;-2.02,-2.06,;-3.35,-1.29,;-4.69,-2.06,;-6.15,-1.59,;-7.06,-2.83,;-6.15,-4.08,;-4.69,-3.6,;-3.35,-4.37,;-8.6,-2.83,;-9.37,-1.5,;-10.91,-1.5,;-11.68,-2.83,;-10.91,-4.17,;-9.37,-4.17,;-13.22,-2.83,;-13.99,-1.5,;-13.99,-4.17,)| Show InChI InChI=1S/C42H41ClN4O7/c1-25-31(5-4-6-33(25)30-12-13-37-35(17-30)46-40(54-37)28-8-10-29(11-9-28)41(48)49)24-53-39-18-38(52-23-27-15-26(19-44)20-45-21-27)32(16-34(39)43)22-47-14-3-2-7-36(47)42(50)51/h4-6,12-13,15-18,20-21,28-29,36H,2-3,7-11,14,22-24H2,1H3,(H,48,49)(H,50,51)/t28?,29?,36-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474543 (US10882844, Example 1008) Show SMILES CN1CCC(C1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r,w:4.6| Show InChI InChI=1S/C40H40ClN5O5/c1-25-30(6-5-7-32(25)28-9-10-36-34(16-28)44-39(51-36)29-11-13-45(2)21-29)24-50-38-17-37(49-23-27-14-26(18-42)19-43-20-27)31(15-33(38)41)22-46-12-4-3-8-35(46)40(47)48/h5-7,9-10,14-17,19-20,29,35H,3-4,8,11-13,21-24H2,1-2H3,(H,47,48)/t29?,35-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.670	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592970 (US11578054, Example 1002) Show SMILES CN1CCCC(COc2cccc(c2Cl)-c2cccc3C(CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)C1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577575 (2-((1-Methyl-3-(oxetan-3-yloxy)-1 H-pyrazol-4-yl)a...) Show SMILES C[C@@H]1COC[C@H]1n1c(cc2cnc(Nc3cn(C)nc3OC3COC3)nc12)C#N |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577571 (2-((1-Methyl-3-(((R)-1 ,1 ,1-trifluoropropan-2-yl)...) Show SMILES C[C@@H](Oc1nn(C)cc1Nc1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1)C(F)(F)F |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577554 (2-[[1-[(1 R)-2,2-Difluoro-1-methyl-ethyl]-3-(oxeta...) Show SMILES C[C@H](C(F)F)n1cc(Nc2ncc3cc(C#N)n([C@H]4COC[C@@H]4C)c3n2)c(OC2COC2)n1 |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577554 (2-[[1-[(1 R)-2,2-Difluoro-1-methyl-ethyl]-3-(oxeta...) Show SMILES C[C@H](C(F)F)n1cc(Nc2ncc3cc(C#N)n([C@H]4COC[C@@H]4C)c3n2)c(OC2COC2)n1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577560 (7-[(3R,4R)-4-Methyltetrahydrofuran-3-yl]-2-[[1-(ox...) Show SMILES C[C@H](ON(c1cnn(c1)C1COC1)c1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1)C(F)(F)F |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577560 (7-[(3R,4R)-4-Methyltetrahydrofuran-3-yl]-2-[[1-(ox...) Show SMILES C[C@H](ON(c1cnn(c1)C1COC1)c1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1)C(F)(F)F |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577571 (2-((1-Methyl-3-(((R)-1 ,1 ,1-trifluoropropan-2-yl)...) Show SMILES C[C@@H](Oc1nn(C)cc1Nc1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1)C(F)(F)F |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM593000 (US11578054, Example 1021) Show SMILES OCC[C@@H](NCc1cc(Cl)c(OC2CCc3c2cccc3-c2cccc(OCCCNC[C@H](O)CO)c2Cl)cc1OCc1cncc(c1)C#N)C(O)=O |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592969 (US11578054, Example 1001) Show SMILES CN1CCCC(COc2cccc(c2Cl)-c2cccc3C(CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)C1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM477010 (US10882844, Example 1027) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2ncc(nc2c1)C1=CCCNC1 |r,t:52| Show InChI InChI=1S/C41H39ClN6O4/c1-26-31(6-4-8-33(26)29-10-11-35-36(16-29)47-37(22-46-35)30-7-5-12-44-21-30)25-52-40-17-39(51-24-28-14-27(18-43)19-45-20-28)32(15-34(40)42)23-48-13-3-2-9-38(48)41(49)50/h4,6-8,10-11,14-17,19-20,22,38,44H,2-3,5,9,12-13,21,23-25H2,1H3,(H,49,50)/t38-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592989 (US11578054, Example 1012) Show SMILES Cc1c(OCCCN2CC[C@@H](O)C2)cccc1-c1cccc2C(CCc12)Oc1cc(OCc2cncc(c2)C#N)c(CN[C@](C)(CO)C(O)=O)cc1Cl |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.80	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592992 (US11578054, Example 1015) Show SMILES Cc1c(OCCCN2CC[C@@H](O)C2)cccc1-c1cccc2C(CCc12)Oc1cc(OCc2cncc(c2)C#N)c(CN[C@@H](CCO)C(O)=O)cc1Cl |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.90	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577557 (2-((1-methyl-3-(((2S,3R)-2-methyloxetan-3-yl)oxy)-...) Show SMILES C[C@@H]1OCC1Oc1nn(C)cc1Nc1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1 |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577557 (2-((1-methyl-3-(((2S,3R)-2-methyloxetan-3-yl)oxy)-...) Show SMILES C[C@@H]1OCC1Oc1nn(C)cc1Nc1ncc2cc(C#N)n([C@H]3COC[C@@H]3C)c2n1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Programmed cell death protein 1 [25-167,N33K], Immunoglobulin heavy constant gamma 1 [99-330,C104S,C109S,C112S,L118I,P121S]/Programmed cell death 1 ligand 1 [18-239,H172E] (Homo sapiens (Human))	BDBM507127 (US11046675, Example 1006) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c3CN(CC(O)=O)CCc3c2Cl)cccc1-c1cccc(OCCCN2CC[C@@H](O)C2)c1C |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q2377CVC
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592987 (US11578054, Example 1010) Show SMILES CN1CCC[C@H](COc2cccc(c2Cl)-c2cccc3[C@@H](CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)C1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577568 (2-((3-(((S)-1-acetyl-2,2-dimethylazetidin-3-yl)oxy...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(C)nc3O[C@H]3CN(C(C)=O)C3(C)C)nc12)C#N |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577564 (2-[[1-(Methylsulfonylmethyl)-3-(oxetan-3-yloxy)pyr...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(CS(C)(=O)=O)nc3OC3COC3)nc12)C#N |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577568 (2-((3-(((S)-1-acetyl-2,2-dimethylazetidin-3-yl)oxy...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(C)nc3O[C@H]3CN(C(C)=O)C3(C)C)nc12)C#N |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577564 (2-[[1-(Methylsulfonylmethyl)-3-(oxetan-3-yloxy)pyr...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(CS(C)(=O)=O)nc3OC3COC3)nc12)C#N |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592997 (US11578054, Example 1019) Show SMILES C[C@](CO)(NCc1cc(Cl)c(OC2CCc3c2cccc3-c2cccc(OCCCNC[C@H](O)CO)c2Cl)cc1OCc1cncc(c1)C#N)C(O)=O |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592996 (US11578054, Example 1018) Show SMILES CC(=O)NC1CCN(CCCOc2cccc(c2Cl)-c2cccc3C(CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CCO)C(O)=O)cc2Cl)CC1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577567 (2-((3-(((R)-1 -Acetyl-2, 2-dimethylazetidin-3-yl)o...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(C)nc3O[C@@H]3CN(C(C)=O)C3(C)C)nc12)C#N |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577567 (2-((3-(((R)-1 -Acetyl-2, 2-dimethylazetidin-3-yl)o...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3cn(C)nc3O[C@@H]3CN(C(C)=O)C3(C)C)nc12)C#N |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 [G2019S] (Homo sapiens (Human))	BDBM577570 (2-((4-(2-Hydroxypropan-2-yl)-2-(oxetan-3-yloxy)phe...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3ccc(cc3OC3COC3)C(C)(C)O)nc12)C#N |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Leucine-rich repeat serine/threonine-protein kinase 2 (Homo sapiens (Human))	BDBM577570 (2-((4-(2-Hydroxypropan-2-yl)-2-(oxetan-3-yloxy)phe...) Show SMILES C[C@H]1COC[C@@H]1n1c(cc2cnc(Nc3ccc(cc3OC3COC3)C(C)(C)O)nc12)C#N |r| Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	WIPO WO2022263472	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The measurements of the activities were made using a LRRK2-G2019S(human) Kinase activity assay as described hereunder. The potency of compounds was e...				Citation and Details BindingDB Entry DOI: 10.7270/Q2S75KKQ
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM592984 (US11578054, Example 1008) Show SMILES CN1CCC[C@H](COc2cccc(c2Cl)-c2cccc3[C@H](CCc23)Oc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)C1 |r| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				Citation and Details BindingDB Entry DOI: 10.7270/Q28P64FR
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474534 (US10882844, Example 1002) Show SMILES CN1CCC(CC1)c1nc2ccc(cc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r| Show InChI InChI=1S/C41H42ClN5O5/c1-26-31(6-5-7-33(26)30-9-10-35-39(18-30)52-40(45-35)29-11-14-46(2)15-12-29)25-51-38-19-37(50-24-28-16-27(20-43)21-44-22-28)32(17-34(38)42)23-47-13-4-3-8-36(47)41(48)49/h5-7,9-10,16-19,21-22,29,36H,3-4,8,11-15,23-25H2,1-2H3,(H,48,49)/t36-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474535 (US10882844, Example 1003) Show SMILES CN1CCCC(C1)c1nc2cc(ccc2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r,w:5.7| Show InChI InChI=1S/C41H42ClN5O5/c1-26-31(7-5-9-33(26)29-11-12-37-35(17-29)45-40(52-37)30-8-6-13-46(2)22-30)25-51-39-18-38(50-24-28-15-27(19-43)20-44-21-28)32(16-34(39)42)23-47-14-4-3-10-36(47)41(48)49/h5,7,9,11-12,15-18,20-21,30,36H,3-4,6,8,10,13-14,22-25H2,1-2H3,(H,48,49)/t30?,36-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474536 (US10882844, Example 1004) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CCNCC1 |r| Show InChI InChI=1S/C40H40ClN5O5/c1-25-30(5-4-6-32(25)29-8-9-36-34(17-29)45-39(51-36)28-10-12-43-13-11-28)24-50-38-18-37(49-23-27-15-26(19-42)20-44-21-27)31(16-33(38)41)22-46-14-3-2-7-35(46)40(47)48/h4-6,8-9,15-18,20-21,28,35,43H,2-3,7,10-14,22-24H2,1H3,(H,47,48)/t35-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474538 (US10882844, Example 1005) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CCN(CC1)C1CC1 |r| Show InChI InChI=1S/C43H44ClN5O5/c1-27-32(5-4-6-35(27)31-8-11-39-37(19-31)47-42(54-39)30-12-15-48(16-13-30)34-9-10-34)26-53-41-20-40(52-25-29-17-28(21-45)22-46-23-29)33(18-36(41)44)24-49-14-3-2-7-38(49)43(50)51/h4-6,8,11,17-20,22-23,30,34,38H,2-3,7,9-10,12-16,24-26H2,1H3,(H,50,51)/t38-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474541 (US10882844, Example 1006) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)C1CC2CCC(C1)N2 |r| Show InChI InChI=1S/C42H42ClN5O5/c1-25-29(5-4-6-34(25)28-8-11-38-36(17-28)47-41(53-38)30-14-32-9-10-33(15-30)46-32)24-52-40-18-39(51-23-27-13-26(19-44)20-45-21-27)31(16-35(40)43)22-48-12-3-2-7-37(48)42(49)50/h4-6,8,11,13,16-18,20-21,30,32-33,37,46H,2-3,7,9-10,12,14-15,22-24H2,1H3,(H,49,50)/t30?,32?,33?,37-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474542 (US10882844, Example 1007) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(nc2c1)-c1ccncc1 |r| Show InChI InChI=1S/C40H34ClN5O5/c1-25-30(5-4-6-32(25)29-8-9-36-34(17-29)45-39(51-36)28-10-12-43-13-11-28)24-50-38-18-37(49-23-27-15-26(19-42)20-44-21-27)31(16-33(38)41)22-46-14-3-2-7-35(46)40(47)48/h4-6,8-13,15-18,20-21,35H,2-3,7,14,22-24H2,1H3,(H,47,48)/t35-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human))	BDBM474544 (US10882844, Example 1009) Show SMILES CN1CCC(CC1)c1nc2cc(cc(C)c2o1)-c1cccc(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)c1C |r| Show InChI InChI=1S/C42H44ClN5O5/c1-26-15-32(18-36-40(26)53-41(46-36)30-10-13-47(3)14-11-30)34-8-6-7-31(27(34)2)25-52-39-19-38(51-24-29-16-28(20-44)21-45-22-29)33(17-35(39)43)23-48-12-5-4-9-37(48)42(49)50/h6-8,15-19,21-22,30,37H,4-5,9-14,23-25H2,1-3H3,(H,49,50)/t37-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 230 total )  |  Next  |  Last  >>

Jump to: